Method of quantitative and/or comparative measurement of...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S091200

Reexamination Certificate

active

07838228

ABSTRACT:
The present invention provides a method for quantitative and/or comparative assessment of the relative amounts of mRNA transcripts present in a cell or tissue sample. In the method reverse transcription of the mRNA contained in the sample is first carried out using sequence-modifying primers for one or several genes in the same reaction to obtain a pool of sequence-modified cDNA molecules. After completion of the reverse transcription redundant sequence-modifying primers are removed or inactivated. This step is followed by a step of co-amplifying the sequence-modified cDNA templates with a reference DNA template in individual gene-specific amplification reactions. By quantitatively measuring the amounts and determining the relative levels of the amplification products derived from sequence-modified cDNA and reference DNA templates, a gene-specific cDNA over DNA ratio is obtained in each of the individual amplification reactions. Finally, by combining the ratios obtained, a sample-specific profile can be generated, which reflects the relative amounts of mRNA transcripts originally present in the sample.

REFERENCES:
patent: 5741676 (1998-04-01), Fuller
patent: 6280931 (2001-08-01), Sakamoto et al.
patent: 6618679 (2003-09-01), Loehrlein et al.
patent: 2003/0022175 (2003-01-01), Terng et al.
patent: 2003/0235884 (2003-12-01), Cummings et al.
patent: 2004/0091857 (2004-05-01), Nallur et al.
patent: 2004/0091921 (2004-05-01), Uematsu et al.
patent: 0 825 265 (1998-02-01), None
patent: 1 279 743 (2003-01-01), None
patent: 2001-78768 (2001-03-01), None
patent: WO-98/35058 (1998-08-01), None
patent: WO-01/02603 (2001-01-01), None
patent: WO-01/20041 (2001-03-01), None
patent: WO-/2005/110596 (2005-11-01), None
Lyon et al. Quantification of HER2
eu gene amplification by competitive PCR using fluorescent melting curve analysis. Clinical Chem. (2001) vol. 47, No. 5, pp. 844-851.
Joo et al., “Differential amplifying RT-PCR: a novel RT-PCR method to differentiate mRNA from its DNA lacking intron,” Journal of Virological Methods, vol. 100, pp. 71-81, (2002). XP-002348045.
Waksman et al., “The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells”, Journal of Pharmacology and Experimental Therapeutics, vol. 288, No. 3, 1999, p. 1357-1366.
Yotsuyanagi et al., “Regulation of Fas gene expression in HeLa cells as determined by modified RT-PCR”, Cell. Mol. Life Sci., vol. 54, 1998, p. 186-190.
Sun et al., “Quantifying porphobilinogen deaminase mRNA in microdissected nephron segments by a modified RT-PCR”, Kidney International, vol. 61, 2002, p. 336-341.
M. E. Zenilman et al., Analytical Biochemistry, 224, No. 1, pp. 339-346, Jan. 1, 1995.
J. Stenman et al., Nature Biotechnology, vol. 17, pp. 720-722, Jul. 1999.
J. Stenman et al., BioTechniques, vol. 34, No. 1, pp. 172-177 (2003).
L Stryer, Biochemistry, 4th ed. Second printing 1995, KP, Part I: Molecular design of life, pp. 139-140.
U.S. Appl. No. 60/569,822, filed May 10, 2004.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of quantitative and/or comparative measurement of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of quantitative and/or comparative measurement of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of quantitative and/or comparative measurement of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4247085

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.